Brind.
  1. Legal shifts are constraining medical practice and patient choices regarding abortion bans and maternal fetal medicine.

The pharmaceutical industry is using fetal tissue obtained from elective abortions in its research and development processes.

1 report, 1 independent Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The pharmaceutical industry is using fetal tissue obtained from elective abortions in its research and development processes.

Who's involved

What this event is mainly about
Stanley Plotkin

Keep exploring

Coverage

Newest first; wire copies grouped